Evidence map›Paper›PMID 24831942›Full record

ArticlePloS one2014

Expression and distribution of the adrenomedullin system in newborn human thymus.

Sara De Martin, Giovanna Paliuri, Annasandra Belloni, Genny Orso, Erica Zanarella, Giovanni Stellin, Ornella Milanesi, Giuseppe Basso, Ezia Maria Ruga, Chiara Frasson and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Sara De MartinDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Giovanna PaliuriDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Annasandra BelloniDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Genny OrsoScientific Institute IRCCS Eugenio Medea, Conegliano, Treviso, Italy.
Erica ZanarellaScientific Institute IRCCS Eugenio Medea, Conegliano, Treviso, Italy.
Giovanni StellinPediatric and Congenital Cardiac Surgery Unit, Department of Cardiac, Thoracic and Vascular Surgery, University of Padova, Padova, Italy.
Ornella MilanesiDepartment of Pediatrics, University of Padova, Padova, Italy.
Giuseppe BassoDepartment of Pediatrics, University of Padova, Padova, Italy.
Ezia Maria RugaDepartment of Pediatrics, University of Padova, Padova, Italy.
Chiara FrassonDepartment of Pediatrics, University of Padova, Padova, Italy.
Daniela GabbiaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Giada PerdoncinDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Pietro PalatiniDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Sergio BovaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
University of Padua · ITIRCCS Eugenio Medea · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenomedullin (AM) is a multifunctional peptide endowed with various biological actions mediated by the interaction with the calcitonin receptor-like receptor (CLR), which couples to the receptor activity-modifying proteins 2 or 3 (RAMP2 or RAMP3) to form the functional plasma membrane receptors AM1 and AM2, respectively. In this study, we investigated for the first time the expression and localization of AM, CLR, RAMP2 and RAMP3 in human thymic tissue from newborns and in primary cultures of thymic epithelial cells (TECs) and thymocytes. Immunohistochemical analysis of thymic tissue showed that both AM and RAMP2 are abundantly expressed in the epithelial cells of medulla and cortex, blood vessels and mastocytes. In contrast, RAMP3 could not be detected. In cultured TECs, double immunofluorescence coupled to confocal microscopy revealed that AM is present in the cytoplasmic compartment, whereas RAMP2 could be detected in the cytoplasm and nucleus, but not in the cell membrane. At variance with RAMP2, CLR was not only present in the nucleus and cytoplasm of TECs, but could also be detected in the cell membrane. The nuclear and cytoplasmic localizations of RAMP2 and CLR and the absence of RAMP2 in the cell membrane were confirmed by western-blot analysis performed on cell fractions. AM, RAMP2 and CLR could also be detected in thymocytes by means of double immunofluorescence coupled to confocal microscopy, although these proteins were not present in the whole thymocyte population. In these cells, AM and RAMP2 were detected in the cytoplasm, whereas CLR could be observed in the cytoplasm and the plasma membrane. In conclusion, our results show that the AM system is widely expressed in human thymus from newborns and suggest that both AM1 receptor components CLR and RAMP2 are not associated with the plasma membrane of TECs and thymocytes but are located intracellularly, notably in the nucleus.

Indexed as

Gene Expression RegulationAdrenomedullinCalcitonin Receptor-Like ProteinCell MembraneCell NucleusCells, CulturedCyclic AMPCytoplasmEpithelial CellsHumansImmunohistochemistryInfant, NewbornMast CellsMicroscopy, FluorescenceProtein BindingReceptor Activity-Modifying Protein 2ADM protein, humanAdrenomedullinCalcitonin Receptor-Like ProteinCALCRL protein, humanCyclic AMPRAMP2 protein, humanRAMP3 protein, humanReceptor Activity-Modifying Protein 2Receptor Activity-Modifying Protein 3

Identifiers

PMID24831942
PMCPMC4022580
OpenAlexW1994846192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.